# Multistrain Probiotics Against Bacterial Vaginosis

> **NCT06888518** · EARLY_PHASE1 · TERMINATED · sponsor: **Institut AllergoSan Pharma GmbH** · enrollment: 56 (actual)

## Conditions studied

- Bacterial Vaginosis (BV)

## Interventions

- **DIETARY_SUPPLEMENT:** OMNi-BiOTiC® FLORA plus+
- **DRUG:** antibiotic

## Key facts

- **NCT ID:** NCT06888518
- **Lead sponsor:** Institut AllergoSan Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-12-12
- **Primary completion:** 2024-06-03
- **Final completion:** 2024-06-03
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** poor recruitment
- **Last updated:** 2025-03-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06888518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06888518, "Multistrain Probiotics Against Bacterial Vaginosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06888518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*